Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy

详细信息    查看全文

• 作者：Zhanguo Li ; Fengchun Zhang ; Jonathan Kay ; Kaiyin Fei ; Chenglong Han ; Yanli Zhuang ; Zhong Wu and Elizabeth C. Hsia
• 刊名：International Journal of Rheumatic Diseases
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：19
• 期：11
• 页码：1143-1156
• 全文大小：201K
• ISSN：1756-185X

文摘

The efficacy and safety of golimumab + methotrexate (MTX) were evaluated in Chinese patients with active rheumatoid arthritis (RA) despite MTX therapy.